25 XP   0   0   10

Purple Biotech Ltd
Buy, Hold or Sell?

Let's analyse Purple Biotech Ltd together

PenkeI guess you are interested in Purple Biotech Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Purple Biotech Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Purple Biotech Ltd

I send you an email if I find something interesting about Purple Biotech Ltd.

Quick analysis of Purple Biotech Ltd (30 sec.)










What can you expect buying and holding a share of Purple Biotech Ltd? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
ILA47.48
Expected worth in 1 year
ILA29.76
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
ILA-17.72
Return On Investment
-72.0%

For what price can you sell your share?

Current Price per Share
ILA24.60
Expected price per share
ILA23.00 - ILA33.00
How sure are you?
50%

1. Valuation of Purple Biotech Ltd (5 min.)




Live pricePrice per Share (EOD)

ILA24.60

2. Growth of Purple Biotech Ltd (5 min.)




Is Purple Biotech Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$34.2m$53.2m-$12.5m-30.9%

How much money is Purple Biotech Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$4.9m-$5.4m$447k9.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Purple Biotech Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#533 / 1031

Most Revenue
#746 / 1031

Most Profit
#456 / 1031

Most Efficient
#194 / 1031

What can you expect buying and holding a share of Purple Biotech Ltd? (5 min.)

Welcome investor! Purple Biotech Ltd's management wants to use your money to grow the business. In return you get a share of Purple Biotech Ltd.

What can you expect buying and holding a share of Purple Biotech Ltd?

First you should know what it really means to hold a share of Purple Biotech Ltd. And how you can make/lose money.

Speculation

The Price per Share of Purple Biotech Ltd is ILA24.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Purple Biotech Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Purple Biotech Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA47.48. Based on the TTM, the Book Value Change Per Share is ILA-4.43 per quarter. Based on the YOY, the Book Value Change Per Share is ILA-6.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Purple Biotech Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.02-0.1%-0.02-0.1%-0.02-0.1%-0.02-0.1%-0.02-0.1%
Usd Book Value Change Per Share-0.02-0.1%-0.010.0%-0.02-0.1%0.010.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.1%-0.010.0%-0.02-0.1%0.010.0%0.010.0%
Usd Price Per Share0.09-0.13-0.22-0.34-0.34-
Price to Earnings Ratio-1.19--1.69--2.88--30.92--30.92-
Price-to-Total Gains Ratio-5.21--218.38--14.36--68.16--68.16-
Price to Book Ratio0.67-0.83-1.10-2.77-2.77-
Price-to-Total Gains Ratio-5.21--218.38--14.36--68.16--68.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.066912
Number of shares14945
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.01
Gains per Quarter (14945 shares)-180.09113.53
Gains per Year (14945 shares)-720.34454.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-720-7300454444
20-1441-14500908898
30-2161-2170013621352
40-2881-2890018161806
50-3602-3610022712260
60-4322-4330027252714
70-5042-5050031793168
80-5763-5770036333622
90-6483-6490040874076
100-7203-7210045414530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%

Fundamentals of Purple Biotech Ltd

About Purple Biotech Ltd

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company for the Phase 2 clinical trials to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy; and Mor Research Applications. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Fundamental data was last updated by Penke on 2024-03-22 00:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Purple Biotech Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Purple Biotech Ltd earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Purple Biotech Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY--262.1%+262.1%
5Y--455.6%+455.6%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Purple Biotech Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • -10.9% Return on Assets means that Purple Biotech Ltd generated -0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Purple Biotech Ltd:

  • The MRQ is -10.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-10.5%-0.4%
TTM-10.5%YOY-9.0%-1.5%
TTM-10.5%5Y-12.5%+2.0%
5Y-12.5%10Y-12.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-12.5%+1.6%
TTM-10.5%-12.2%+1.7%
YOY-9.0%-11.2%+2.2%
5Y-12.5%-13.4%+0.9%
10Y-12.5%-14.7%+2.2%
1.1.3. Return on Equity

Shows how efficient Purple Biotech Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • -14.1% Return on Equity means Purple Biotech Ltd generated -0.14 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Purple Biotech Ltd:

  • The MRQ is -14.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.1%TTM-12.4%-1.7%
TTM-12.4%YOY-10.3%-2.1%
TTM-12.4%5Y-16.2%+3.8%
5Y-16.2%10Y-16.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.1%-15.8%+1.7%
TTM-12.4%-15.7%+3.3%
YOY-10.3%-13.9%+3.6%
5Y-16.2%-18.3%+2.1%
10Y-16.2%-19.2%+3.0%

1.2. Operating Efficiency of Purple Biotech Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Purple Biotech Ltd is operating .

  • Measures how much profit Purple Biotech Ltd makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Purple Biotech Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY--279.7%+279.7%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Purple Biotech Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Purple Biotech Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-3.615-3.615
5Y-5.560-5.560
10Y-7.396-7.396

1.3. Liquidity of Purple Biotech Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Purple Biotech Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.20 means the company has 2.20 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Purple Biotech Ltd:

  • The MRQ is 2.198. The company is able to pay all its short-term debts. +1
  • The TTM is 3.302. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.198TTM3.302-1.104
TTM3.302YOY5.816-2.515
TTM3.3025Y7.683-4.382
5Y7.68310Y7.6830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1983.986-1.788
TTM3.3024.440-1.138
YOY5.8165.552+0.264
5Y7.6836.158+1.525
10Y7.6836.492+1.191
1.3.2. Quick Ratio

Measures if Purple Biotech Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.13 means the company can pay off 0.13 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Purple Biotech Ltd:

  • The MRQ is 0.128. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.188. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.128TTM0.188-0.059
TTM0.188YOY3.109-2.922
TTM0.1885Y4.007-3.819
5Y4.00710Y4.0070.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1283.638-3.510
TTM0.1884.168-3.980
YOY3.1095.515-2.406
5Y4.0076.012-2.005
10Y4.0076.209-2.202

1.4. Solvency of Purple Biotech Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Purple Biotech Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Purple Biotech Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Purple Biotech Ltd assets are financed with 22.6% credit (debt) and the remaining percentage (100% - 22.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Purple Biotech Ltd:

  • The MRQ is 0.226. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.148. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.226TTM0.148+0.077
TTM0.148YOY0.117+0.032
TTM0.1485Y0.153-0.004
5Y0.15310Y0.1530.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2260.335-0.109
TTM0.1480.330-0.182
YOY0.1170.267-0.150
5Y0.1530.367-0.214
10Y0.1530.378-0.225
1.4.2. Debt to Equity Ratio

Measures if Purple Biotech Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 29.2% means that company has 0.29 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Purple Biotech Ltd:

  • The MRQ is 0.292. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.179. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.179+0.114
TTM0.179YOY0.133+0.046
TTM0.1795Y0.200-0.021
5Y0.20010Y0.2000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2920.376-0.084
TTM0.1790.398-0.219
YOY0.1330.334-0.201
5Y0.2000.429-0.229
10Y0.2000.476-0.276

2. Market Valuation of Purple Biotech Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Purple Biotech Ltd generates.

  • Above 15 is considered overpriced but always compare Purple Biotech Ltd to the Biotechnology industry mean.
  • A PE ratio of -1.19 means the investor is paying -1.19 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Purple Biotech Ltd:

  • The EOD is -0.920. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.193. Based on the earnings, the company is expensive. -2
  • The TTM is -1.693. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.920MRQ-1.193+0.273
MRQ-1.193TTM-1.693+0.500
TTM-1.693YOY-2.877+1.184
TTM-1.6935Y-30.919+29.226
5Y-30.91910Y-30.9190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.920-2.643+1.723
MRQ-1.193-2.418+1.225
TTM-1.693-2.742+1.049
YOY-2.877-4.123+1.246
5Y-30.919-6.257-24.662
10Y-30.919-6.478-24.441
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Purple Biotech Ltd:

  • The EOD is -0.892. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.156. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.736. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.892MRQ-1.156+0.265
MRQ-1.156TTM-1.736+0.580
TTM-1.736YOY-3.476+1.740
TTM-1.7365Y-2.839+1.103
5Y-2.83910Y-2.8390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.892-3.244+2.352
MRQ-1.156-2.939+1.783
TTM-1.736-3.478+1.742
YOY-3.476-5.592+2.116
5Y-2.839-8.473+5.634
10Y-2.839-8.881+6.042
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Purple Biotech Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.67 means the investor is paying 0.67 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Purple Biotech Ltd:

  • The EOD is 0.518. Based on the equity, the company is cheap. +2
  • The MRQ is 0.672. Based on the equity, the company is cheap. +2
  • The TTM is 0.830. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.518MRQ0.672-0.154
MRQ0.672TTM0.830-0.158
TTM0.830YOY1.099-0.269
TTM0.8305Y2.771-1.941
5Y2.77110Y2.7710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5182.124-1.606
MRQ0.6722.041-1.369
TTM0.8302.118-1.288
YOY1.0992.915-1.816
5Y2.7713.682-0.911
10Y2.7714.114-1.343
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Purple Biotech Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---6.121-4.430-28%-6.232+2%2.793-319%2.793-319%
Book Value Per Share--47.47756.344-16%73.777-36%70.962-33%70.962-33%
Current Ratio--2.1983.302-33%5.816-62%7.683-71%7.683-71%
Debt To Asset Ratio--0.2260.148+52%0.117+94%0.153+48%0.153+48%
Debt To Equity Ratio--0.2920.179+64%0.133+120%0.200+47%0.200+47%
Dividend Per Share----0%-0%-0%-0%
Eps---6.683-6.970+4%-7.499+12%-7.496+12%-7.496+12%
Free Cash Flow Per Share---6.897-6.8970%-5.870-15%-6.028-13%-6.028-13%
Free Cash Flow To Equity Per Share---1.019-4.975+388%-5.485+438%-5.071+398%-5.071+398%
Gross Profit Margin--1.0001.0000%1.0000%0.941+6%0.941+6%
Market Cap6533390803.200-30%8472161244.80012602007870.400-33%21957239213.600-61%33393407082.353-75%33393407082.353-75%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.518-30%0.6720.830-19%1.099-39%2.771-76%2.771-76%
Pe Ratio-0.920+23%-1.193-1.693+42%-2.877+141%-30.919+2491%-30.919+2491%
Price Per Share24.600-30%31.90047.450-33%82.675-61%125.735-75%125.735-75%
Price To Free Cash Flow Ratio-0.892+23%-1.156-1.736+50%-3.476+201%-2.839+146%-2.839+146%
Price To Total Gains Ratio-4.019+23%-5.211-218.375+4090%-14.360+176%-68.161+1208%-68.161+1208%
Quick Ratio--0.1280.188-32%3.109-96%4.007-97%4.007-97%
Return On Assets---0.109-0.105-4%-0.090-17%-0.125+15%-0.125+15%
Return On Equity---0.141-0.124-12%-0.103-27%-0.162+15%-0.162+15%
Total Gains Per Share---6.121-4.430-28%-6.232+2%2.793-319%2.793-319%
Usd Book Value--34297274.37640702075.614-16%53295926.364-36%51261998.328-33%51261998.328-33%
Usd Book Value Change Per Share---0.017-0.012-28%-0.017+2%0.008-319%0.008-319%
Usd Book Value Per Share--0.1290.153-16%0.201-36%0.193-33%0.193-33%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.018-0.019+4%-0.020+12%-0.020+12%-0.020+12%
Usd Free Cash Flow---4982039.856-4982039.8560%-4240783.926-15%-3073965.768-38%-3073965.768-38%
Usd Free Cash Flow Per Share---0.019-0.0190%-0.016-15%-0.016-13%-0.016-13%
Usd Free Cash Flow To Equity Per Share---0.003-0.014+388%-0.015+438%-0.014+398%-0.014+398%
Usd Market Cap17770822.985-30%23044278.58634277461.407-33%59723690.661-61%90830067.264-75%90830067.264-75%
Usd Price Per Share0.067-30%0.0870.129-33%0.225-61%0.342-75%0.342-75%
Usd Profit---4828038.624-4970039.760+3%-5417043.336+12%-5172394.320+7%-5172394.320+7%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.017-0.012-28%-0.017+2%0.008-319%0.008-319%
 EOD+3 -5MRQTTM+8 -18YOY+12 -175Y+11 -1910Y+11 -19

3.2. Fundamental Score

Let's check the fundamental score of Purple Biotech Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.920
Price to Book Ratio (EOD)Between0-10.518
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.128
Current Ratio (MRQ)Greater than12.198
Debt to Asset Ratio (MRQ)Less than10.226
Debt to Equity Ratio (MRQ)Less than10.292
Return on Equity (MRQ)Greater than0.15-0.141
Return on Assets (MRQ)Greater than0.05-0.109
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Purple Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose24.300
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets44,302
Total Liabilities10,005
Total Stockholder Equity34,207
 As reported
Total Liabilities 10,005
Total Stockholder Equity+ 34,207
Total Assets = 44,302

Assets

Total Assets44,302
Total Current Assets15,788
Long-term Assets28,514
Total Current Assets
Cash And Cash Equivalents 14,489
Short-term Investments 923
Other Current Assets 171
Total Current Assets  (as reported)15,788
Total Current Assets  (calculated)15,583
+/- 205
Long-term Assets
Property Plant Equipment 470
Long-term Assets  (as reported)28,514
Long-term Assets  (calculated)470
+/- 28,044

Liabilities & Shareholders' Equity

Total Current Liabilities7,183
Long-term Liabilities2,822
Total Stockholder Equity34,207
Total Current Liabilities
Accounts payable 3,532
Total Current Liabilities  (as reported)7,183
Total Current Liabilities  (calculated)3,532
+/- 3,651
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt351
Long-term Liabilities  (as reported)2,822
Long-term Liabilities  (calculated)351
+/- 2,471
Total Stockholder Equity
Total Stockholder Equity (as reported)34,207
Total Stockholder Equity (calculated)0
+/- 34,207
Other
Common Stock Shares Outstanding 252,379
Net Invested Capital 34,207
Net Working Capital 8,605
Property Plant and Equipment Gross 470



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
14,718
0
85,783
0
83,803
81,954
76,491
73,628
70,198
66,294
61,740
58,543
54,622
53,082
47,999
45,272
44,302
44,30245,27247,99953,08254,62258,54361,74066,29470,19873,62876,49181,95483,803085,783014,7180
   > Total Current Assets 
8,302
8,302
65,160
65,160
59,282
59,282
57,442
50,001
47,197
48,473
41,899
37,447
34,306
33,256
24,410
19,384
16,718
15,788
15,78816,71819,38424,41033,25634,30637,44741,89948,47347,19750,00157,44259,28259,28265,16065,1608,3028,302
       Cash And Cash Equivalents 
0
4,385
0
62,995
0
11,247
10,195
10,540
9,117
10,890
23,537
14,006
11,074
15,030
21,883
17,202
15,104
14,489
14,48915,10417,20221,88315,03011,07414,00623,53710,8909,11710,54010,19511,247062,99504,3850
       Short-term Investments 
0
2,010
0
10
0
46,558
45,258
37,846
36,447
36,310
16,010
22,010
22,010
17,083
1,235
1,198
980
923
9239801,1981,23517,08322,01022,01016,01036,31036,44737,84645,25846,55801002,0100
       Net Receivables 
3,493
3,493
1,000
1,000
500
500
500
500
500
0
0
0
0
0
0
0
0
0
0000000005005005005005001,0001,0003,4933,493
       Other Current Assets 
182
182
1,155
1,155
197
197
1,489
1,115
1,133
268
2,352
1,431
1,222
146
1,292
984
634
171
1716349841,2921461,2221,4312,3522681,1331,1151,4891971971,1551,155182182
   > Long-term Assets 
0
6,416
0
20,623
0
24,521
24,512
26,490
26,431
21,725
24,395
24,293
24,237
21,366
28,672
28,615
28,554
28,514
28,51428,55428,61528,67221,36624,23724,29324,39521,72526,43126,49024,51224,521020,62306,4160
       Property Plant Equipment 
244
244
141
141
968
968
959
991
931
896
867
780
725
682
628
571
510
470
470510571628682725780867896931991959968968141141244244
       Long Term Investments 
0
0
0
0
0
0
0
0
0
187
187
187
187
0
0
0
0
0
00000187187187187000000000
       Intangible Assets 
0
6,172
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000006,1720
       Other Assets 
0
0
0
0
3,071
3,071
3,071
5,017
5,018
160
2,657
2,642
2,641
0
0
0
0
0
000002,6412,6422,6571605,0185,0173,0713,0713,0710000
> Total Liabilities 
0
3,859
0
29,638
0
4,051
6,860
4,367
4,254
5,092
7,975
6,085
6,433
7,524
6,036
5,254
6,553
10,005
10,0056,5535,2546,0367,5246,4336,0857,9755,0924,2544,3676,8604,051029,63803,8590
   > Total Current Liabilities 
3,546
3,546
29,384
29,384
3,098
3,098
5,973
3,497
3,426
4,250
7,188
5,394
5,933
7,058
5,617
4,876
6,220
7,183
7,1836,2204,8765,6177,0585,9335,3947,1884,2503,4263,4975,9733,0983,09829,38429,3843,5463,546
       Accounts payable 
1,245
1,245
2,965
2,965
1,198
1,198
1,335
2,071
2,083
1,473
1,651
1,227
2,765
2,132
2,451
1,572
2,593
3,532
3,5322,5931,5722,4512,1322,7651,2271,6511,4732,0832,0711,3351,1981,1982,9652,9651,2451,245
       Other Current Liabilities 
961
961
26,310
26,310
1,693
1,693
4,431
1,227
1,144
18
5,338
3,972
2,975
10
0
3,120
0
0
003,1200102,9753,9725,338181,1441,2274,4311,6931,69326,31026,310961961
   > Long-term Liabilities 
0
313
0
254
0
953
887
870
828
842
787
691
500
466
419
378
333
2,822
2,822333378419466500691787842828870887953025403130
       Capital Lease Obligations Min Short Term Debt
0
223
0
117
0
895
829
804
762
749
694
594
550
515
467
421
370
351
351370421467515550594694749762804829895011702230
> Total Stockholder Equity
0
10,421
0
55,744
0
79,389
74,753
71,799
69,061
64,827
58,060
55,411
51,891
46,911
46,884
42,605
38,598
34,207
34,20738,59842,60546,88446,91151,89155,41158,06064,82769,06171,79974,75379,389055,744010,4210
   Common Stock000000000000000000
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
12,957
12,957
29,600
29,600
38,001
38,001
36,744
37,281
37,681
36,781
36,906
37,198
37,706
38,077
0
37,949
0
0
0037,949038,07737,70637,19836,90636,78137,68137,28136,74438,00138,00129,60029,60012,95712,957



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-22,271
Operating Income-22,271-22,271
 
Operating Expense (+$)
Research Development17,034
Selling General Administrative4,842
Selling And Marketing Expenses-
Operating Expense22,27121,876
 
Net Interest Income (+$)
Interest Income474
Interest Expense-56
Other Finance Cost-2,125
Net Interest Income-1,707
 
Pretax Income (+$)
Operating Income-22,271
Net Interest Income-1,707
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-19,977-26,272
EBIT - interestExpense = -56
-19,880
-19,824
Interest Expense56
Earnings Before Interest and Taxes (EBIT)--19,921
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-19,977
Tax Provision--
Net Income From Continuing Ops-19,977-19,977
Net Income-19,880
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net4,0011,707
 

Technical Analysis of Purple Biotech Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Purple Biotech Ltd. The general trend of Purple Biotech Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Purple Biotech Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Purple Biotech Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.90 < 26.10 < 33.00.

The bearish price targets are: 23.00.

Tweet this
Purple Biotech Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Purple Biotech Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Purple Biotech Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Purple Biotech Ltd.

Purple Biotech Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPurple Biotech Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Purple Biotech Ltd. The current adx is .

Purple Biotech Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Purple Biotech Ltd.

Purple Biotech Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Purple Biotech Ltd.

Purple Biotech Ltd Daily Relative Strength Index (RSI) ChartPurple Biotech Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Purple Biotech Ltd.

Purple Biotech Ltd Daily Stochastic Oscillator ChartPurple Biotech Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Purple Biotech Ltd.

Purple Biotech Ltd Daily Commodity Channel Index (CCI) ChartPurple Biotech Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Purple Biotech Ltd.

Purple Biotech Ltd Daily Chande Momentum Oscillator (CMO) ChartPurple Biotech Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Purple Biotech Ltd.

Purple Biotech Ltd Daily Williams %R ChartPurple Biotech Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Purple Biotech Ltd.

Purple Biotech Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Purple Biotech Ltd.

Purple Biotech Ltd Daily Average True Range (ATR) ChartPurple Biotech Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Purple Biotech Ltd.

Purple Biotech Ltd Daily On-Balance Volume (OBV) ChartPurple Biotech Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Purple Biotech Ltd.

Purple Biotech Ltd Daily Money Flow Index (MFI) ChartPurple Biotech Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Purple Biotech Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Purple Biotech Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Purple Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose24.300
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Purple Biotech Ltd with someone you think should read this too:
  • Are you bullish or bearish on Purple Biotech Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Purple Biotech Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Purple Biotech Ltd

I send you an email if I find something interesting about Purple Biotech Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Purple Biotech Ltd.

Receive notifications about Purple Biotech Ltd in your mailbox!